Nitto Denko Corporation

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
    • Specialty Pharmaceuticals
  • Medical Devices
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools

Other Names/Subsidiaries

  • Altea Therapeutics Corporation
  • Avecia Biotechnology, Inc.
  • Nitto BioPharma, Inc.
See more in Biomedtracker

Latest on Nitto Denko Corporation

Scrip

Asia Deal Watch: Astellas Invests In Taysha, Gets Rights To Two AAV Gene Therapies

 
• By Ian Haydock, Anju Ghangurde, Dexter Jie Yan, and Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. $50m Taysha Investment Gives Astel

Scrip

Pipeline Watch: Phase III Progress With Avelumab, Ixekizumab And Eravacycline

 
• By John Davis

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

Scrip

J&J Innovation’s Latest Deal Spree Includes CB-1 Antibody For NASH

 
• By Joseph Haas

In unveiling its latest round of collaborations, Johnson & Johnson Innovation LLC announced a collaboration with an option to acquire with Bird Rock Bio on a Phase I antibody targeting cannabinoid

In Vivo

Deals Shaping the Medical Industry, December 2016

 
• By Steven Muntner, Beth Allan, Maureen Riordan, Deanna Kamienski, and Amanda Micklus

IN VITRO DIAGNOSTICS Alliances Allergan PLC T2 Biosystems Inc. T2 Biosystems Inc. and Allergan PLC are teaming up to develop a diagnostic panel to detect Gram-negative bacteria and antibiotic